抗NMDAR脑炎与原发性精神病的神经丝轻链水平
本观察性研究检测抗NMDAR脑炎(NMDARe)、原发性精神病性障碍首次发作(pFEP)、单纯疱疹病毒脑炎(HSE)患者及健康对照的血神经丝轻链(sNfL)。sNfL区分NMDARe孤立精神病与pFEP的曲线下面积为0.93,阈值≥15 pg/mL时灵敏度85%、特异度96%;sNfL≥15 pg/mL的青年FEP患者患NMDARe的比值比为120.4。
要点
- sNfL≥15 pg/mL区分NMDARe孤立精神病与pFEP的灵敏度85%、特异度96%,阳性似然比19.3。
- sNfL≥15 pg/mL的青年FEP患者患NMDARe的比值比为120.4(95% CI 21.8-664,p<0.001)。
- NMDARe诊断时NfL水平与1年改良Rankin量表评估的结局不相关。
核心结论
- NMDARe诊断时NfL与疾病严重程度特征相关,但与长期结局不相关。
- sNfL≥15 pg/mL的青年FEP患者患NMDARe的几率是pFEP患者的120倍。
- 该阈值正确分类了96%的pFEP患者和85%的NMDARe孤立精神病患者。
研究设计与样本
- 观察性研究,采用单分子阵列技术检测NfL水平。
- 纳入118例NMDARe患者(其中33例起病时表现为孤立精神病)、45例pFEP患者、36例HSE患者和36名健康对照,后两组作为对照。
- 采用受试者工作特征(ROC)分析评估血清NfL(sNfL)对NMDARe和pFEP的预测准确性并获取临床可用的截断值。
主要发现
- NMDARe患者中,有癫痫发作/癫痫持续状态、入住重症监护室、脑脊液细胞增多(>20个白细胞/µL)且未接受早期免疫治疗者,其NfL(主要在脑脊液)高于无这些特征者。
- NMDARe诊断时NfL水平与1年随访时改良Rankin量表评估的结局不相关。
- NMDARe患者的sNfL显著高于pFEP患者和健康对照,但低于HSE患者。
- sNfL区分NMDARe孤立精神病与pFEP的ROC曲线下面积为0.93(95% CI 0.87-0.99),截断值≥15 pg/mL的灵敏度85%、特异度96%、阳性似然比19.3。
- pFEP患者中43/45(96%)sNfL<15 pg/mL,而NMDARe孤立精神病患者中仅5/33(15%)低于该 cutoff;风险估计NMDARe vs pFEP:比值比120.4(95% CI 21.8-664),p<0.001。
关键数值与推荐
- sNfL区分NMDARe孤立精神病与pFEP的曲线下面积为0.93(95% CI 0.87-0.99)。
- sNfL截断值≥15 pg/mL区分NMDARe孤立精神病与pFEP:灵敏度85%、特异度96%、阳性似然比19.3。
- pFEP患者中43/45(96%)sNfL<15 pg/mL,NMDARe孤立精神病患者中5/33(15%)sNfL<15 pg/mL。
- HSE患者中0例sNfL<15 pg/mL,健康对照中35/36(97%)sNfL<15 pg/mL。
- sNfL≥15 pg/mL的青年FEP患者患NMDARe的比值比为120.4(95% CI 21.8-664),p<0.001。
临床怎么用
- 作者认为,病因不明的FEP且sNfL≥15 pg/mL的患者应接受脑脊液NMDAR抗体检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: An important challenge in diagnosing anti-NMDA receptor (NMDAR) encephalitis (NMDARe) is differentiating it from a first episode of psychosis (FEP) caused by a psychiatric disease (pFEP). CSF antibody testing distinguishes these diseases, but spinal taps are difficult to obtain in psychiatric facilities. A separate problem is the lack of biomarkers of NMDARe severity and outcome. Here we assessed the performance of neurofilament light chain (NfL) testing in these settings. METHODS: In this observational study, NfL levels were determined with single-molecule array in patients with NMDARe, pFEP, herpes simplex encephalitis (HSE), and healthy participants (HC), with the last 2 groups used as controls. Receiver operating characteristic (ROC) analyses were performed to assess the prediction accuracy of serum NfL (sNfL) levels for NMDARe and pFEP and to obtain clinically useful cutoffs. RESULTS: One hundred eighteen patients with NMDARe (33 with isolated psychosis at presentation), 45 with pFEP, 36 with HSE, and 36 HC were studied. Patients with NMDARe with seizures/status epilepticus, intensive care unit admission, and CSF pleocytosis (>20 white blood cells/µL) and without early immunotherapy were more likely to have higher NfL (mainly in CSF) than individuals with NMDARe without these features. NfL levels at diagnosis of NMDARe did not correlate with outcome at 1-year follow-up assessed with the modified Rankin Scale. Patients with NMDARe had significantly higher sNfL than individuals with pFEP and HC and lower sNfL than patients with HSE. ROC analysis of sNfL between NMDARe with isolated psychosis and pFEP provided an area under the curve of 0.93 (95% CI 0.87-0.99) and an sNfL cutoff ≥15 pg/mL to distinguish these disorders (sensitivity 85%, specificity 96%, positive likelihood ratio 19.3). Forty-three of 45 (96%) patients with pFEP had sNfL<15 pg/mL, whereas only 5 of 33 (15%) with NMDARe with isolated psychosis were below this cutoff (risk estimation NMDARe vs pFEP: odds ratio 120.4 [95% CI 21.8-664], p < 0.001). None of the patients with HSE and 35 of 36 (97%) HC had sNfL<15 pg/mL. DISCUSSION: NfL measured at diagnosis of NMDARe associated with features of disease severity but not with long-term outcome. Young patients with FEP and sNfL ≥15 pg/mL had a 120 times higher chance of having NMDARe than those with pFEP. This cutoff correctly classified 96% of patients with pFEP and 85% of patients with NMDARe with isolated psychosis. Patients with FEP of unclear etiology and sNfL ≥15 pg/mL should undergo CSF NMDAR antibody testing.
引用
- Guasp M, Martín-Aguilar L, Sabater L, et al. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis. Neurology. 2022. PMID: 35145006. doi:10.1212/WNL.0000000000200021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。